Instil Bio, Inc.
corporate_fare Company Profile
Instil Bio, Inc. (NASDAQ:TIL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for TIL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-15, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for TIL spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Instil Bio Reports Sharply Reduced Q1 Loss, Extends Cash Runway Beyond 2027, Reverses Tarzana Facility Sale
- Instil Bio Extends Cash Runway Beyond 2027, Mitigating Going Concern Risk
- Instil Bio Posts Q1 Net Loss of $4.2M, EPS -$0.62, Reinforcing Going Concern Doubts
- Instil Bio Discloses Going Concern Doubt, Discontinues Lead Product, and Reports Significant Asset Impairment in Annual Filing
- Instil Bio Reports Strong Cash Position Exceeding Market Cap, Pivots to M&A for Strategic Development
Financial Snapshot
Short Interest & Short Volume
13.13 days to coverFINRA reported short interest of 161,870 shares in TIL as of the September 15, 2026 settlement, a 3.2% increase from the prior period — about 13.1 days to cover at its recent average daily volume. On October 2, 2026, 20.3% of TIL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.